{"id":9739,"date":"2025-05-07T22:36:43","date_gmt":"2025-05-07T20:36:43","guid":{"rendered":"https:\/\/aliber.org\/web\/?p=9739"},"modified":"2025-05-07T22:36:43","modified_gmt":"2025-05-07T20:36:43","slug":"como-mejorar-el-acceso-a-tratamientos-de-las-enfermedades-raras-en-latinoamerica","status":"publish","type":"post","link":"https:\/\/aliber.org\/web\/2025\/05\/07\/como-mejorar-el-acceso-a-tratamientos-de-las-enfermedades-raras-en-latinoamerica\/","title":{"rendered":"C\u00f3mo mejorar el acceso a tratamientos de las enfermedades raras en Latinoam\u00e9rica"},"content":{"rendered":"<p>Dr. Emilio Rold\u00e1n \u2013 Representante de ICORD e IRDiRC<\/p>\n<p>El Dr. Emilio Rold\u00e1n analiz\u00f3 las principales barreras que enfrentan los pa\u00edses de Am\u00e9rica Latina para garantizar el acceso a tratamientos para enfermedades raras.<\/p>\n<p>Subray\u00f3 la necesidad de avanzar hacia marcos regionales de colaboraci\u00f3n, mayor reconocimiento de los medicamentos hu\u00e9rfanos, acceso y armonizaci\u00f3n ministerial para negociaciones.<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-9740 size-full\" src=\"https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/Roldan.jpeg\" alt=\"\" width=\"739\" height=\"1600\" srcset=\"https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/Roldan.jpeg 739w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/Roldan-139x300.jpeg 139w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/Roldan-473x1024.jpeg 473w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/05\/Roldan-709x1536.jpeg 709w\" sizes=\"(max-width: 739px) 100vw, 739px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Emilio Rold\u00e1n \u2013 Representante de ICORD e IRDiRC El Dr. Emilio Rold\u00e1n analiz\u00f3 las principales barreras que enfrentan los pa\u00edses de Am\u00e9rica Latina para garantizar el acceso a tratamientos<a href=\"https:\/\/aliber.org\/web\/2025\/05\/07\/como-mejorar-el-acceso-a-tratamientos-de-las-enfermedades-raras-en-latinoamerica\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":1,"featured_media":9740,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[2,8,3,138],"tags":[],"class_list":["post-9739","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aliber","category-encuentros","category-eventos","category-noticias"],"_links":{"self":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/9739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/comments?post=9739"}],"version-history":[{"count":1,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/9739\/revisions"}],"predecessor-version":[{"id":9741,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/9739\/revisions\/9741"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media\/9740"}],"wp:attachment":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media?parent=9739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/categories?post=9739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/tags?post=9739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}